Skip to main content
All lobbying filings

DLA PIPER LLP (US)

Lobbying for PRELUDE CORPORATION (PRELUDEDX) · Precision cancer diagnostics company.

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$70,000.00
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 3
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Health Issues

Improved patient access to cancer screening diagnostics.

Medicare/Medicaid

Policies related to Medicare reimbursement for cancer diagnostics.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem